A phase I/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis (Q40790584)
scientific article
Language:
Current Data About A phase I/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis
(P31) (Q13442814)
(P248)
(P698) 10555022
(P813) Saturday, September 23, 2017

(P304) 2286-2292
(P248)
(P698) 10555022
(P813) Saturday, September 23, 2017

(P407) (Q1860)

(P433) 11
(P248)
(P698) 10555022
(P813) Saturday, September 23, 2017

(P478) 42
(P248)
(P698) 10555022
(P813) Saturday, September 23, 2017

(P577) Monday, November 1, 1999
(P248)
(P698) 10555022
(P813) Saturday, September 23, 2017

(P1433) (Q4797636)
(P248)
(P698) 10555022
(P813) Saturday, September 23, 2017

(P1476) "A phase I/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis" (language: en)
(P248)
(P698) 10555022
(P813) Saturday, September 23, 2017

(P2093) Snowden JA
(P1545) 1
(P248)
(P698) 10555022
(P813) Saturday, September 23, 2017

Biggs JC
(P1545) 2
(P248)
(P698) 10555022
(P813) Saturday, September 23, 2017

Milliken ST
(P1545) 3
(P248)
(P698) 10555022
(P813) Saturday, September 23, 2017

Fuller A
(P1545) 4
(P248)
(P698) 10555022
(P813) Saturday, September 23, 2017

Brooks PM
(P1545) 5
(P248)
(P698) 10555022
(P813) Saturday, September 23, 2017

(P2860) (Q33635723)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1529-0131%28199911%2942%3A11%3C2286%3A%3AAID-ANR5%3E3.0.CO%3B2-X
(P813) Sunday, January 21, 2018

(Q41474821)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1529-0131%28199911%2942%3A11%3C2286%3A%3AAID-ANR5%3E3.0.CO%3B2-X
(P813) Sunday, January 21, 2018

(Q37117517)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1529-0131%28199911%2942%3A11%3C2286%3A%3AAID-ANR5%3E3.0.CO%3B2-X
(P813) Sunday, January 21, 2018

(Q36094809)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1529-0131%28199911%2942%3A11%3C2286%3A%3AAID-ANR5%3E3.0.CO%3B2-X
(P813) Sunday, January 21, 2018

(Q28329020)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1529-0131%28199911%2942%3A11%3C2286%3A%3AAID-ANR5%3E3.0.CO%3B2-X
(P813) Sunday, January 21, 2018

(Q27860872)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1529-0131%28199911%2942%3A11%3C2286%3A%3AAID-ANR5%3E3.0.CO%3B2-X
(P813) Sunday, January 21, 2018

(Q40409000)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1529-0131%28199911%2942%3A11%3C2286%3A%3AAID-ANR5%3E3.0.CO%3B2-X
(P813) Sunday, January 21, 2018

(Q40936051)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1529-0131%28199911%2942%3A11%3C2286%3A%3AAID-ANR5%3E3.0.CO%3B2-X
(P813) Sunday, January 21, 2018

(Q56879288)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1529-0131%28199911%2942%3A11%3C2286%3A%3AAID-ANR5%3E3.0.CO%3B2-X
(P813) Sunday, January 21, 2018

(Q69916482)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1529-0131%28199911%2942%3A11%3C2286%3A%3AAID-ANR5%3E3.0.CO%3B2-X
(P813) Sunday, January 21, 2018

(Q70996656)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1529-0131%28199911%2942%3A11%3C2286%3A%3AAID-ANR5%3E3.0.CO%3B2-X
(P813) Sunday, January 21, 2018

(Q77758591)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1529-0131%28199911%2942%3A11%3C2286%3A%3AAID-ANR5%3E3.0.CO%3B2-X
(P813) Sunday, January 21, 2018

(Q77701325)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1529-0131%28199911%2942%3A11%3C2286%3A%3AAID-ANR5%3E3.0.CO%3B2-X
(P813) Sunday, January 21, 2018

(Q74324034)
(P248)
(P854) https://api.crossref.org/works/10.1002%2F1529-0131%28199911%2942%3A11%3C2286%3A%3AAID-ANR5%3E3.0.CO%3B2-X
(P813) Sunday, January 21, 2018